117 related articles for article (PubMed ID: 1706483)
21. Etoposide, carmustine, bleomycin, and methotrexate with leucovorin rescue as re-treatment for unfavorable non-Hodgkin's lymphoma.
Helms SR; Oblon DJ; Braylan RC; Weiner RS
Cancer Treat Rep; 1985; 69(7-8):783-6. PubMed ID: 2410118
[TBL] [Abstract][Full Text] [Related]
22. Tandem transplant of peripheral blood stem cells for patients with poor-prognosis Hodgkins's disease or non-Hodgkin's lymphoma.
Fitoussi O; Simon D; Brice P; Makke J; Scrobohaci ML; Bibi Triki T; Hennequin C; Fermé C; Gisselbrecht C
Bone Marrow Transplant; 1999 Oct; 24(7):747-55. PubMed ID: 10516678
[TBL] [Abstract][Full Text] [Related]
23. Combination chemotherapy with COP-BLAM III for intermediate and high-grade non-Hodgkin's lymphoma.
Niitsu N; Umeda M
Int J Hematol; 1994 Jul; 60(1):71-8. PubMed ID: 7522616
[TBL] [Abstract][Full Text] [Related]
24. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
25. Comparison of carbon monoxide (CO) single breath pulmonary diffusing capacity with non-rebreathing, open-circuit CO pulmonary diffusing capacity in healthy children.
Suman OE; Thomas S; Beck KC; Mlcak RP; Herndon DN
Pediatr Pulmonol; 2006 Nov; 41(11):1095-102. PubMed ID: 16986167
[TBL] [Abstract][Full Text] [Related]
26. [Role of single-breath carbon monoxide-diffusing capacity in monitoring the bleomycin-induced lung toxicity in human].
Wang JL; Ma SQ; Zhang YJ; Han JN; Zhu YJ; Ma Y; Shen K; Li LY
Zhonghua Nei Ke Za Zhi; 2003 Oct; 42(10):709-12. PubMed ID: 14633466
[TBL] [Abstract][Full Text] [Related]
27. Long-term pulmonary function in survivors of childhood Hodgkin disease and non-Hodgkin lymphoma.
Oguz A; Tayfun T; Citak EC; Karadeniz C; Tatlicioglu T; Boyunaga O; Bora H
Pediatr Blood Cancer; 2007 Oct; 49(5):699-703. PubMed ID: 17420991
[TBL] [Abstract][Full Text] [Related]
28. Effect of treatment for Hodgkin's disease on pulmonary function: results of a prospective study.
Horning SJ; Adhikari A; Rizk N; Hoppe RT; Olshen RA
J Clin Oncol; 1994 Feb; 12(2):297-305. PubMed ID: 7509383
[TBL] [Abstract][Full Text] [Related]
29. [Type III procollagen N-terminal peptide and type IV collagen-7S level in the serum and BALF of patients with non-Hodgkin's lymphoma before and after chemotherapy].
Niitsu N; Umeda M
Rinsho Ketsueki; 1994 Nov; 35(11):1267-75. PubMed ID: 7529840
[TBL] [Abstract][Full Text] [Related]
30. Carbon monoxide diffusing capacity is a poor predictor of clinically significant bleomycin lung. New Zealand Clinical Oncology Group.
McKeage MJ; Evans BD; Atkinson C; Perez D; Forgeson GV; Dady PJ
J Clin Oncol; 1990 May; 8(5):779-83. PubMed ID: 1692088
[TBL] [Abstract][Full Text] [Related]
31. Bleomycin in the reticuloses.
European Organization for Research on the Treatment of Cancer, Co-Operative Group for Leukaemia and Reticulocytoses
Br Med J; 1972 Jan; 1(5795):285-6. PubMed ID: 4109401
[TBL] [Abstract][Full Text] [Related]
32. Bleomycin-associated Lung Toxicity in Childhood Cancer Survivors.
Zorzi AP; Yang CL; Dell S; Nathan PC
J Pediatr Hematol Oncol; 2015 Nov; 37(8):e447-52. PubMed ID: 26422284
[TBL] [Abstract][Full Text] [Related]
33. Effects of bleomycin on pulmonary function in man.
Pascual RS; Mosher MB; Sikand RS; De Conti RC; Bouhuys A
Am Rev Respir Dis; 1973 Aug; 108(2):211-7. PubMed ID: 4124394
[No Abstract] [Full Text] [Related]
34. Prolonged administration of bleomycin without clinical toxicity. Therapy with 2,700 units over four years.
Kurnick JE
Chest; 1977 Dec; 72(6):798-9. PubMed ID: 72636
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary function impairment measured by pulmonary function tests in long-term survivors of childhood cancer.
Mulder RL; Thönissen NM; van der Pal HJ; Bresser P; Hanselaar W; Koning CC; Oldenburger F; Heij HA; Caron HN; Kremer LC
Thorax; 2011 Dec; 66(12):1065-71. PubMed ID: 21803931
[TBL] [Abstract][Full Text] [Related]
36. Treatment of advanced lymphomas with bleomycin (NSC-125066).
Durkin WJ; Pugh RP; Solomon J; Rosen P; Pajak TF; Bateman JR
Oncology; 1976; 33(3):140-5. PubMed ID: 64951
[TBL] [Abstract][Full Text] [Related]
37. Bleomycin pulmonary toxicity in adult Saudi patients with Hodgkin's lymphoma.
Al-Jizani WA; Al-Mansour MM; Al-Fayea TM; Shafi RU; Kazkaz GA; Bayer AM; Al-Foheidi ME; Ibrahim EM
Future Oncol; 2015; 11(15):2149-57. PubMed ID: 26235180
[TBL] [Abstract][Full Text] [Related]
38. Impact of hemoglobin levels on hemoglobin-adjusted carbon monoxide diffusion capacity after chemotherapy for testicular cancer.
Nitta S; Kawai K; Nagumo Y; Ikeda A; Kandori S; Kojima T; Nishiyama H
Jpn J Clin Oncol; 2019 Dec; 49(12):1151-1156. PubMed ID: 31361805
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary function abnormalities in childhood cancer survivors treated with bleomycin.
De A; Guryev I; LaRiviere A; Kato R; Wee CP; Mascarenhas L; Keens TG; Venkatramani R
Pediatr Blood Cancer; 2014 Sep; 61(9):1679-84. PubMed ID: 24789770
[TBL] [Abstract][Full Text] [Related]
40. A prospective study of pulmonary function in Hodgkin's lymphoma patients.
Ng AK; Li S; Neuberg D; Chi R; Fisher DC; Silver B; Mauch PM
Ann Oncol; 2008 Oct; 19(10):1754-8. PubMed ID: 18467315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
